Fundraising Fox
BioCryst Pharmaceuticals
NASDAQ: BCRX1 known investors
Find your way into BioCryst Pharmaceuticals
Sign up to see every warm intro you have to BioCryst Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioCryst Pharmaceuticals team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BioCryst is a global biotechnology company focused on drug discovery, development, and commercialization of oral small-molecule and injectable protein therapeutics. It develops novel medicines for patients with hereditary angioedema (HAE) and other rare diseases.
Founders & leadership
Investors · 1
Frequently asked questions
- What does BioCryst Pharmaceuticals do?
- BioCryst is a global biotechnology company focused on drug discovery, development, and commercialization of oral small-molecule and injectable protein therapeutics. It develops novel medicines for patients with hereditary angioedema (HAE) and other rare diseases.
- Who are BioCryst Pharmaceuticals's investors?
- BioCryst Pharmaceuticals's investors include Invivo Capital Partners.